ライフサイエンスコーパス: vial

1 sample volume (150 nL droplets versus 10 mL vials).

2 suctioned and collected into a sterile empty vial.

3 monolayer compressions in a rotating closed vial.

4 ons, compared with bevacizumab directly from vial.

5 rded, was inoculated into an aerobic culture vial.

6 mpler (injector) needle pickup from a sample vial.

7 ntegrate during the transfer to the sampling vial.

8 e resin and sterilely filtered into a sealed vial.

9 rbent, and eluted with solvent into a sample vial.

10 ion of C. trachomatis in a single collection vial.

11 tion into a single BACTEC MYCO/F LYTIC (MFL) vial.

12 were related to providing <5 doses per open vial.

13 us particles) were loaded to the autosampler vial.

14 tities of material to be dispensed into each vial.

15 lume, pull up delay and volume in the sample vial.

16 and concentration within a single collection vial.

17 ein (330 attomole) loaded in the autosampler vial.

18 ion of the detection window to the electrode vial.

19 genera were isolated from the implicated MPA vials.

20 es in the loops are removed and collected in vials.

21 ever used but discarded as whole ampoules or vials.

22 cement in BBL Port-A-Cul anaerobic transport vials.

23 ml aliquots to aerobic and anaerobic culture vials.

24 BTEXS from blood during transfer into sample vials.

25 ge lipids on a micrometer scale in picoliter vials.

26 e span in population cages, and life span in vials.

27 mixed-sex population cages and in single-sex vials.

28 y of bloodstream pathogen detection with MFL vials.

29 d sample was inoculated into each of two MFL vials.

30 xpensive, off-the-shelf, preevacuated, glass vials.

31 dified with 4 M H(2)SO(4) in sealed reaction vials.

32 r antibiotic vials as well as growth control vials.

33 e of [3H] thymidine and sucrose within glass vials.

34 als, and mandatory destruction of empty drug vials.

35 lony growth was measured from the Optisol-GS vials.

36 ut the requirement for specialized headspace vials.

37 ernated with 92 previously negative ThinPrep vials.

38 assay on aliquots from reprocessed ThinPrep vials.

39 cold chain or separate adjuvant and antigen vials.

40 e close proximity to known-positive ThinPrep vials.

41 as observed in all voriconazole-supplemented vials.

42 Candida glabrata were each added to a set of vials.

43 eak and was also confirmed from unopened MPA vials.

44 vasive manner, through the side of the glass vials.

45 d cell study in the pharmacy 12 hours before vial 1 was prepared.

46 njections drawn from a single pharmacy vial (vial 1).

47 The small volume of these vials (100-200 pL) allows rapid mixing of all of the sol

48 at caution is warranted when prescribing >10 vials (1000 mg) of iron dextran over a period of 6 mo.

49 e of atmospheric CO2 remaining in the loaded vial, (2) impact of helium flush, (3) sampling speed.

50 Of the 10 microL of sample per well, as with vials, 5 microL is injected into the microflow NMR probe

51 Of 228 paired vials, 51 (22%) were both positive, 172 (75%) were both

52 mping of the Kezzler code on all bevacizumab vials, a real-time digital verification process between

53 e accumulation of nonanal in sealed reaction vials, accounting for the other product of the acyl chai

54 In most of the nonapproved cases, a 4.8-mg vial administered to an adult patient weighing 50-100 kg

55 Staining of R-Mix vials after overnight incubation allowed initial detecti

56 the analyte during injection from the sample vial allowed greatly extended sample plug injection leng

57 e microparticles onto the side of the sample vial, allowing detection of naphthalene by surface-enhan

58 Zero-voltage injections from the smallest vials also demonstrate additional injection discrepancie

59 g metallic silver foil and a stainless-steel vial and ball system.

60 meters: thermostatting time and temperature, vial and desorption pressure, number of extraction cycle

61 d 14, 1 mL of solution was removed from each vial and incubated at 36 degrees C for 48 hours.

62 ations such as centrifugation-enhanced shell vial and multiwell plate cultures and the use of genetic

63 olvents followed by a transfer into a sample vial and subsequent liquid chromatography-tandem mass sp

64 ducts are eluted directly into scintillation vials and counted.

65 sed by standard methods, and then BACTEC 12B vials and Middlebrook 7H11/7H115 plates were inoculated,

66 readings of 90Y sources in glass and plastic vials and plastic syringes were accurate at either dial

67 y can be conducted entirely in scintillation vials and quantitated by addition of appropriate aqueous

68 a cold chain, waste of vaccine in multidose vials and risks associated with needle use and disposal.

69 d on the B. juncea seedlings grown in closed vials and treated with Se.

70 rococci because of oritavancin's sticking to vials and tubes.

71 the number of needles and the number of drug vials and unbroken glass bottles ("trash") to control fo

72 e supernate is transferred to an autosampler vial, and 10 microL is injected into the LC-MS/MS system

73 abscesses, 6 isolates from contaminated NECC vials, and 7 isolates unrelated to the outbreak.

74 g on composition (A vs A/C), number of doses/vials, and presentation.

75 Since the vials are discarded after use, no cleaning is necessary,

76 These vials are fabricated using photolithography and KOH etch

77 Vials are filled with CO2 and H2O and shaken in a consta

78 Septa-sealed vials are used along with commercially available disposa

79 on of intravenous anesthesia when medication vials are used for multiple patients using incorrect tec

80 ium pH and inoculum densities for antibiotic vials as well as growth control vials.

81 luated a cytomegalovirus (CMV) 24-hour shell vial assay (SVA), the Murex Hybrid Capture CMV DNA assay

82 icor plasma PCR assay) with a standard shell vial assay in detecting and predicting cytomegalovirus (

83 No specimens were positive by the shell vial assay only.

84 Application of the vial assay to the analysis of amorpha-4,11-diene synthas

85 fied with 4 of 19 subjects positive in shell vial assay, and 8 of 18 positive for CMV gene products (

86 evaluation of PCR with histopathology, shell-vial assay, and tube culture of intestinal biopsy specim

87 tion was 100%, compared to 71% for the shell vial assay.

88 echniques such as enzyme immunoassays, shell vial assays, and culture tube assays (year 1) to patient

89 With the collection vial at 25 atm, the trapping efficiencies of different s

90 uvant components that are stable in a single vial at sustained elevated temperatures.

91 ectively, were stored in Microbank cryogenic vials at >/=-130 degrees C in liquid nitrogen and at -70

92 ions (3.5 mL) were dripped from spiked 50-mL vials at each hour for 12 hrs.

93 rowave irradiation steps in the same reactor vial, avoiding the need for additional reaction purifica

94 cultured from an opened multidose supplement vial (BBL Septi-Chek AFB Supplement) that had been used

95 41 patients with bacteremia had only one MFL vial been inoculated.

96 NDA/CN- is placed in the inlet vial between the sampling capillary and channel so that

97 puncture and blood collection in specialized vials by a phlebotomist along with centrifugation and re

98 wareness of how long a reconstituted measles vial can be used before it must be discarded (+14%).

99 The vials can be purchased in bulk from scientific apparatus

100 ositive samples) compared with that of shell vial cell culture (69 of 88 samples identified as positi

101 ection of VZV from dermal specimens by shell vial cell culture (MRC-5) and by LightCycler PCR.

102 ively positive by LightCycler PCR; the shell vial cell culture assay was never positive when DNA ampl

103 enty-five patients had CMV viremia (by shell vial cell culture assay) and/or tissue-invasive disease

104 traction methods were also positive by shell vial cell culture assay.

105 tion, and equivalent costs compared to shell vial cell culture for detection of VZV indicate the need

106 targets) and by conventional tube and shell vial cell culture.

107 38; number of ocular specimens, 2) by shell vial cell cultures (MRC-5) and by LightCycler PCR.

108 mens, VZV was detected in 23 (9.1%) by shell vial cell cultures and 44 (17.4%) by LightCycler PCR dir

109 tected, 69 (78%) were detected by both shell vial cell cultures and LightCycler PCR (DNA polymerase t

110 ion of human metapneumovirus (HMPV) in shell vial centrifugation cultures (SVCC).

111 We compared five, one-vial commercial preservatives, two from Meridian Diagnos

112 However, when the vial contained a single HEK-293 cell transfected to expr

113 is by placing the disk into a GC autosampler vial containing 1 mL of N,O-bis(trimethylsilyl)trifluoro

114 up to 5 mL of headspace sample from a 20 mL vial containing 13 mL of aqueous solution and 5 g of NaC

115 ess this, a reusable standard gas generating vial containing pentafluorophenyl hydrazine (PFPH) has b

116 n was taken, placed into a ThinPrep Pap test vial containing PreservCyt liquid cytology medium, and t

117 In this method, a sample vial containing proteins suspended in a solubilization r

118 )Ga by adding generator eluate directly to a vial containing the cold precursors THP-PSMA and sodium

119 f various amounts of this brush initiator to vials containing a photocleavable bis-norbornene cross-l

120 in DMSO-d6 are submitted for NMR analysis in vials containing as little as 10 microL of sample.

121 Degradation rates in vials containing FeS exceeded those in Na(2)S-only contr

122 volume allows exhaustive electrolysis of the vial contents with a 3-microm radius, disk-shaped carbon

123 ty that one 72-bp virions contaminated those vials could not be tested.

124 ed after 45 min of acetone fixation of shell vial coverslips.

125 cent-antibody (DFA) staining and rapid shell vial culture (R-mix cells; Diagnostic Hybrids, Inc.

126 levels were determined by quantitative shell vial culture and quantitative-competitive PCR with blood

127 We analyzed a shell vial culture assay (SVA), real-time PCR, and a direct fl

128 combination of immunofluorescence and shell vial culture currently implemented at the University of

129 Whereas the sensitivity of shell vial culture progressively declined, with only 55% posit

130 za A and B virus immunoassay and rapid shell vial culture were 70.3% and 98.6%, respectively.

131 ories (including amoeba co-culture and shell-vial culture) and through the use of matrix-assisted las

132 The comparative sensitivities of PCR, shell vial culture, and conventional culture were 91%, 44%, an

133 Shell vial culture, conventional culture, and polymerase chain

134 ts with CMV infection as determined by shell vial culture.

135 for CMV by cytopathology, conventional shell vial cultures, and antigen detection.

136 gradation is increased with smaller sampling vials, decreased capillary-electrode distances, and incr

137 corporates a robotic arm for handling sample vials delivered to the laboratory, and several auxiliary

138 y applying an electric field from the sample vial directly into the capillary, with neutral analytes

139 Our study shows that a second MFL vial does not significantly increase diagnostic sensitiv

140 nolayer of granular spheres in a cylindrical vial, driven continuously by an orbital shaker and subje

141 Here, we describe an in-vial dual extraction (IVDE) method and a direct injectio

142 ide mass in the headspace of a closed sample vial during the bacteria growth.

143 d since solutions were in borosilicate glass vials during irradiation resulting from increasingly low

144 eled antibodies can be predried to the assay vials, e.g., microtiter plate wells, and readout is read

145 Two vials each were supplemented with amphotericin B at conc

146 supplied by a commercial manufacturer (bulk vial eluted from a generator).

147 In each of 27 vials examined, cells had the rpoS start codon UUG inste

148 ther organism in amphotericin B-supplemented vials, except at 0.25x and 0.5x MIC on day 2, when viabl

149 An in-vial extraction and UHPLC-MS analysis method was first d

150 atrix of leucine, high-yield, free-flowing, "vial-fillable" powders of bacteria (including M. smegmat

151 upernatant was cleaned-up using d-SPE and in-vial filtration with a combination of anhydrous CaCl2 (1

152 In-vial filtration with dispersive solid-phase extraction (

153 rried out by applying pressure to the sample vial followed by the subsequent sweeping and separation

154 muL of the sample in and out of the tip in a vial for approximately 1 min.

155 olyzed, and derivatized in a single reaction vial for routine analysis by GC-MS.

156 yl-tryptophan in nitrogen gas-sparged Teflon vials for 0-144 h at 110 degrees C.

157 res undisturbed in sealed nutrient agar stab vials for 34 to 45 years offered a unique opportunity to

158 s compared to viral culture with R-Mix shell vials for 455 nasal-wash or nasal-aspirate specimens.

159 andard 96-/384-well plates, Petri dishes, or vials for cloning, PCR, and other single-cell biochemica

160 lapses included using single-dose medication vials for more than 1 patient (18/64; 28.1%; 95% CI, 18.

161 the national switch date, removing any tOPV vials found.

162 After 24 hours, 1 vial from each pair was exposed to light for the remaind

163 nondestructively verify the quality of every vial from the point of release to the point of care.

164 Twenty-seven tissue product vials from a donor were distributed to facilities in 7 s

165 Unopened heparin vials from facilities that reported reactions were teste

166 isposal of tOPV included removal of all tOPV vials from the cold chain, placement in appropriate bags

167 was detected by culture and qPCR in 2 unused vials from the donor.

168 lready in the cells from the original frozen vials from the same ATCC lot, however, STR markers did n

169 buted to facilities in 7 states; at least 20 vials from this donor were used in 14 patients.

170 -3) x 10 for the respective ampoule and dose vial geometries with an expanded (at a presumed 95% conf

171 The setting for the dose vial geometry was independently confirmed using a Capint

172 mab sampled directly from the original glass vial had particle counts of 63,839 +/- 349/mL.

173 ted patients who received doses from 6 other vials had acute HCV infection.

174 icroL, and 110-microL stainless steel sample vials have been investigated using a six-analyte mixture

175 Preevacuated vials have been used by others for the isotopic analysis

176 /grafting) and emerged from their cells into vials held in an incubator at 34C.

177 ased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translamin

178 Inoculation of one vial, however, would be expected to reduce the sensitivi

179 that a potential problem with the TB antigen vials in a certain tube lot was the likely cause of the

180 y adjusts drug concentrations inside culture vials in order to maintain a constant drug-induced inhib

181 gradation reactions were also carried out in vials (in vitro) with a total reaction volume of 400 muL

182 rements of ATP and glucose in pharmaceutical vials (including mixtures of ATP and glucose) were carri

183 Medication vials incorporating electronic monitor circuits in their

184 philic and hydrophilic layer within a single vial insert, we showed that analytical variation was dec

185 was adapted to use 1.5 mL glass autosampler vials instead, which facilitated sampling and circumvent

186 Vial-inversion tests and rheology show that ThT increase

187 tion conditions that exist in the adenovirus vial, is obtained by direct boundary modeling of the AUC

188 >99% similarity between patient and unopened vial isolates.

189 repared by either a ligand exchange or a one-vial kit.

190 led by the pharmacy; examination of unopened vials later revealed fungus.

191 They developed higher vial loads, more severe lung pathology, and greater infl

192 horesis (CE) system with flow-through sample vial made in-house and action control programming was as

193 trifugal inoculation (spinoculation or shell vial methods), the underlying mechanism of enhancement h

194 re of mink lung and A549 cell lines in shell vials (MSVs) for the detection of respiratory viruses in

195 Puncturing single-use vials multiple times and pooling preservative-free epoet

196 ral companies and are often presented as one-vial, non-mercuric chloride fixatives that aim at perfor

197 In sealed vials, O2 concentrations in solutions containing liver s

198 ial of drug can be avoided by using a single vial of bevacizumab for each eye or by following strict

199 r 797 requirements when compounding a single vial of bevacizumab into multiple syringes.

200 b-containing syringes prepared from the same vial of drug can be avoided by using a single vial of be

201 Because a vial of frozen cells can now provide the capacity to pro

202 ho inappropriately used a single-patient-use vial of propofol for multiple patients.

203 A 100-microg vial of toxin taken from the same manufacturer's lot as

204 lectrode, moving sequentially through the 24 vials of a standard 6 x 4 microtiter plate.

205 was isolated from pooled epoetin alfa, empty vials of epoetin alfa that had been pooled, antibacteria

206 revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and

207 h a standard inoculum prepared directly from vials of frozen, virulent, El Tor Inaba V. cholerae N169

208 Vials of heparin manufactured by Baxter from facilities

209 Bills for <or=10 vials of iron over 6 mo also showed no significant assoc

210 in multivariable analysis, bills for <or=10 vials of iron over 6 mo showed no adverse effect on surv

211 nkage between clinical isolates and injected vials of MPA, and described significant features of the

212 cy study measured fungal colony growth in 10 vials of Optisol-GS supplemented with different concentr

213 fungal colony-forming units from inoculated vials of optisol-GS taken at 2 different processing temp

214 Twenty vials of Optisol-GS were supplemented with either vorico

215 rs of research-grade donor corneas and 20-mL vials of Optisol-GS.

216 btained what appear to be the last available vials of poliovaccine produced in 1955.

217 Twelve current vials of poliovaccines tested uniformly negative for SV4

218 d the impact of incorporation of R-Mix shell vials on the sensitivity and time to detection of seven

219 icle sizes into several different collection vials on the tens of milligrams scale.

220 n aqueous solution of gentamicin sulphate in vials or ampoules and requires health care workers to be

221 to perform either rapid diagnostics (single vial) or the high-throughput (96-well plate) analysis of

222 C/Y/W-135-DT meningococcal conjugate vaccine vial, or in a final formulated bulk, accurate identifica

223 s was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer us

224 Prescribing iron in quantities of <or=10 vials over 6 mo had no association with an elevated risk

225 re is formulated in glass gas chromatography vials, overlaid with organic solvent such as ethyl aceta

226 e discard vial versus 10.5% for the standard vial (P = 0.90).

227 We evaluated a single-vial peptide vaccine consisting of nine HLA-A2 supertype

228 cines (28%), lack of knowledge on multi-dose vial policy (30%) and age of IPV administration (8%).

229 ction are lower, implementing the multi-dose vial policy, and encouraging the use of fractional dose

230 nt of LightCycler PCR results with all shell vial positive results indicate the potential for routine

231 Among the 13 shell vial-positive lower respiratory samples, the percent sen

232 ctions drawn from select radiopharmaceutical vials prepared on October 14-15, 2004, at a single nucle

233 The effects of different collection vial pressures were evaluated.

234 Ninety-two ThinPrep vials previously positive for high-risk human papillomav

235 ddition of glacial acetic acid to the sample vial prior to performing SPME.

236 It was also thought that all poliovaccine vials produced from 1955 until 1963 had been discarded,

237 f our knowledge, the standard gas generating vial proposed in this work is the first documented devic

238 simple, 1-step, room-temperature syringe-and-vial radiolabeling of (68)Ga radiopharmaceuticals.

239 0.06, 0.12, or 0.225 mug/mL; the remaining 2 vials received no C albicans inoculation and no antifung

240 s as target analytes demonstrated intrabatch vial reproducibility (2% relative standard deviation (RS

241 Growth control vials required two to three inoculum dilutions, which va

242 l assay, loss of C60 due to sorption to test vials resulted in the reduction of exposure-solution con

243 ant levels of MTBE were identified in sample vial septa that use poly(dimethylsiloxane) (PDMS)-based

244 m.s(-1) through fish scales, forced through vial septa, and employed in a targeted study of polyunsa

245 ainer stoppers, syringe plungers, and sample vial septa.

246 ues of 15-200 mg Pt/L), but also in a double-vial setup, separating cells from PtNPs, thus demonstrat

247 ) when compared with none, but bills for >10 vials showed a statistically significant elevated rate o

248 , 0.83 to 1.03; P = 0.15), but bills for >10 vials showed statistically significant elevated risk (ad

249 ECOFIX is a single-vial stool preservative that is both formalin- and mercu

250 A bridged two-vial system aminocarbonylation protocol where Mo(CO)(6)

251 However, NIR has been used as a single-vial technique and thus is not representative of the ent

252 ltivation in Vero cell cultures by the shell vial technique with individual A. cooperi ticks resulted

253 acking on-site molecular capabilities, shell vial techniques can rapidly (about 1 day) confirm negati

254 ling 0.2 mL of cold (4 degrees C) cider in a vial that is passed in an ultrasonic bath for 10 min at

255 eactions are performed in 10 mL borosilicate vials that are sealed with a silicone cap and Teflon sep

256 elevation of the pressure on the collection vial, the flow may be reduced and trapping efficiency im

257 When mixed together in the same vial, the progeny of species I replicate preferentially

258 For 5 of 27 (19%) vials, the final disposition could not be confirmed.

259 For nanoliter-volume conductive vials, the injection process creates new species and eli

260 tal variance both within and among replicate vials, the significance of genetic variation among wild-

261 used for multiple extractions from the same vial, thus conserving the sample necessary for analysis

262 idyl)propane (dpp) lead in a single reaction vial to the simultaneous formation of three different si

263 s to ensure long-term stability and separate vials to enable bedside mixing of antigen and adjuvant.

264 Thus, we were able to use three buffer vials to perform CE experiments in the capillary by appl

265 cturer provided vaccine and placebo in coded vials to preserve blinding.

266 va was collected from subjects into separate vials under resting conditions and during chewing-stimul

267 The two phases in the vial, upper and lower, underwent HPLC-QTOF analysis on i

268 , with resulting contamination of medication vials used for subsequent patients, likely resulted in v

269 Validation of the vial using C4-C9 linear aldehyde standards as target ana

270 ysaccharide concentrations of A/C/Y/W-135 in vialed vaccine or from formulated final bulks.

271 Overall CR were 10.9% for the discard vial versus 10.5% for the standard vial (P = 0.90).

272 50 muL donor phase at the bottom of a sample vial, via an immiscible organic filter phase, into a 2 m

273 ical injections drawn from a single pharmacy vial (vial 1).

274 s than of wild type remained adherent to the vial walls.

275 n by either precipitation or sorption to the vial walls.

276 Wastage per 5-dose vaccine vial was above the recommended 30% in 20 health faciliti

277 Finally, the PFPH-generating vial was applied to the monitoring of volatile aldehydes

278 inated in 33 (5.1%); and only the "standard" vial was contaminated in 31 (4.7%).

279 nated in 38 pairs (5.8%); only the "discard" vial was contaminated in 33 (5.1%); and only the "standa

280 g system using ethylene vinyl acetate coated vials was developed to eliminate the incomplete dissolut

281 say for the detection of biotin in picoliter vials was developed using the photoprotein aequorin as t

282 mes, and residual epoetin alfa from multiple vials was pooled and administered to patients.

283 ter (containing 3g of NaCl in a 40-mL sample-vial) was microwave irradiated at 80 W for 5 min.

284 In these vials, we detected and sequenced SV40 containing only on

285 spectively) calibrated 90Y sources in either vial were -3.0 and +4.3%, respectively, at dial-setting

286 5-mL NIST ampoule and in a 5-mL SoloPak dose vial were calibrated using 4pibeta liquid scintillation

287 Mixed Mv1Lu and A549 cells in a single shell vial were synergistic for detection of influenza virus A

288 les with known positive results by CMV shell vial were tested by each PCR method.

289 t of 653 IVC-drawn blood culture pairs, both vials were contaminated in 38 pairs (5.8%); only the "di

290 m the conjugates at the bottom of the sample vials were easily visualized by the naked eye under ultr

291 The vials were fabricated from fused-silica capillaries that

292 rate experiments, aliquots from 236 ThinPrep vials were forwarded for tandem analysis with and withou

293 The vials were incubated for 72 h, and aliquots were removed

294 In total, 821 ThinPrep vials were tested using both assays.

295 In this study, R-Mix shell vials were used as part of the culture of 3803 respirato

296 the neurotransmitter dopamine in a picoliter vial with electrochemical techniques.

297 Water containing EDB was incubated in sealed vials with various combinations of Na(2)S (<0.7 mM) and

298 on IFNalpha2b (a portion of 10 million IU/ml vial) with follow-up every 1 to 3 months.

299 monitor the concentration of analyte in the vial without depleting its contents.

300 All previously negative ThinPrep vials yielded a negative result following routine automa